ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.438,35
1,47%
S&P 500
5.195,64
0,29%
Dow Jones
38.925,70
0,19%
Euro vs US Dollar
1,0775
0,07%
Bitcoin
63.790,92
0,99%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Exicure Inc (XCUR)

  7. Exicure Inc (XCUR) News

XCUR

Exicure (XCUR)

Exicure Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XCUR
DatumZeitQuelleÜberschriftSymbolFirma
22/04/202422h01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KNASDAQ:XCURExicure Inc
06/03/202418h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
05/03/202400h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
04/03/202423h37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XCURExicure Inc
05/02/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
05/02/202422h01Business WireExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisNASDAQ:XCURExicure Inc
16/01/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
02/12/202300h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
01/12/202322h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
28/11/202322h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
28/11/202322h01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QNASDAQ:XCURExicure Inc
14/11/202322h28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
06/10/202323h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
29/09/202323h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
27/09/202323h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
13/09/202323h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
31/08/202319h33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
31/08/202319h33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
31/08/202319h32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
23/08/202315h48Business WireExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of DirectorsNASDAQ:XCURExicure Inc
23/08/202315h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
19/08/202300h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
11/08/202322h33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
11/08/202322h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
11/08/202322h01Business WireExicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
09/08/202322h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
04/08/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
14/07/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
14/07/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
14/07/202322h01Business WireExicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
 Showing the most relevant articles for your search:NASDAQ:XCUR

Kürzlich von Ihnen besucht

TG
ALV
Allianz
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
TG
MBG
MercedesBenz
NYSE
MRK
Merck
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
TG
BAYN
Bayer
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
TG
LHA
Deutsche Lufthansa
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten